Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignacio Melero

Showing results (31-40 of 351) with videos related to

Pageof 36
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2016
Immunotherapy of Cancer Visualized by Live Microscopy: Seeing Is BelievingAlvaro Teijeira, Iñaki Etxeberria, Mariano Ponz-Sarvise, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2018
Revisiting Interleukin-12 as a Cancer Immunotherapy AgentPedro Berraondo, Iñaki Etxeberria, Mariano Ponz-Sarvise, et al.
Nature Reviews. Gastroenterology & Hepatology|April 14, 2021
Advances in immunotherapy for hepatocellular carcinomaBruno Sangro, Pablo Sarobe, Sandra Hervás-Stubbs, et al.
Cancer Discovery|November 1, 2024
Immunogenicity and Efficacy of Personalized Adjuvant mRNA Cancer VaccinesPedro Berraondo, Raquel Cuesta, Miguel F Sanmamed, et al.
Oncoimmunology|July 26, 2014
Combinations of immunostimulatory antibodies with synergistic effects against spontaneous cancerAizea Morales-Kastresana, Sara Labiano, Ines Gütgemann, et al.
ESMO Open|July 3, 2020
New emerging targets in cancer immunotherapy: CD137/4-1BB costimulatory axisIñaki Etxeberria, Javier Glez-Vaz, Álvaro Teijeira, et al.
Cancer Discovery|May 6, 2014
T-cell and NK-cell infiltration into solid tumors: a key limiting factor for efficacious cancer immunotherapyIgnacio Melero, Ana Rouzaut, Greg T Motz, et al.
Cancer Discovery|August 3, 2019
Immune Desertic Landscapes in Hepatocellular Carcinoma Shaped by β-Catenin ActivationPedro Berraondo, Maria C Ochoa, Irene Olivera, et al.
Advances in Clinical Chemistry|April 24, 2008
Immunosuppression routed via the kynurenine pathway: a biochemical and pathophysiologic approachAlvaro González, Nerea Varo, Estibaliz Alegre, et al.
Nature Reviews. Clinical Oncology|May 19, 2021
Intratumoural administration and tumour tissue targeting of cancer immunotherapiesIgnacio Melero, Eduardo Castanon, Maite Alvarez, et al.
Pageof 36

Showing results (31-40 of 351) with videos related to

Sort By:
Pageof 36
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2016
Immunotherapy of Cancer Visualized by Live Microscopy: Seeing Is BelievingAlvaro Teijeira, Iñaki Etxeberria, Mariano Ponz-Sarvise, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2018
Revisiting Interleukin-12 as a Cancer Immunotherapy AgentPedro Berraondo, Iñaki Etxeberria, Mariano Ponz-Sarvise, et al.
Nature Reviews. Gastroenterology & Hepatology|April 14, 2021
Advances in immunotherapy for hepatocellular carcinomaBruno Sangro, Pablo Sarobe, Sandra Hervás-Stubbs, et al.
Cancer Discovery|November 1, 2024
Immunogenicity and Efficacy of Personalized Adjuvant mRNA Cancer VaccinesPedro Berraondo, Raquel Cuesta, Miguel F Sanmamed, et al.
Oncoimmunology|July 26, 2014
Combinations of immunostimulatory antibodies with synergistic effects against spontaneous cancerAizea Morales-Kastresana, Sara Labiano, Ines Gütgemann, et al.
ESMO Open|July 3, 2020
New emerging targets in cancer immunotherapy: CD137/4-1BB costimulatory axisIñaki Etxeberria, Javier Glez-Vaz, Álvaro Teijeira, et al.
Cancer Discovery|May 6, 2014
T-cell and NK-cell infiltration into solid tumors: a key limiting factor for efficacious cancer immunotherapyIgnacio Melero, Ana Rouzaut, Greg T Motz, et al.
Cancer Discovery|August 3, 2019
Immune Desertic Landscapes in Hepatocellular Carcinoma Shaped by β-Catenin ActivationPedro Berraondo, Maria C Ochoa, Irene Olivera, et al.
Advances in Clinical Chemistry|April 24, 2008
Immunosuppression routed via the kynurenine pathway: a biochemical and pathophysiologic approachAlvaro González, Nerea Varo, Estibaliz Alegre, et al.
Nature Reviews. Clinical Oncology|May 19, 2021
Intratumoural administration and tumour tissue targeting of cancer immunotherapiesIgnacio Melero, Eduardo Castanon, Maite Alvarez, et al.
Pageof 36